Skip to main content

16-06-2018 | Osteoarthritis | Article

Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: A meta-analysis of randomized controlled trials

Persson MSM et al. Rheumatology (Oxford) 2018: key131. doi: 10.1093/rheumatology/key131

Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.

Related topics